FDA approval offers hope for prevention of acute graft-versus-host disease | Dana-Farber/Boston Children's Cancer and Blood...
FDA approval offers hope for prevention of acute graft-versus-host disease ... Approval of the drug abatacept opens up bone marrow transplant as an option for many more patients with cancer or blood ... Acute GVHD is a potentially life-threatening complication in which T cells in the transplanted donor bone marrow attack the ... The U.S. Food and Drug Administration (FDA) today approved a treatment to prevent acute graft-versus-host disease (GVHD) in ...